针对儿童急性呼吸道感染的植物疗法:一个系统地进行的,全面的审查
Wolfgang Kamin1, Georg Seifert2, Karl Zwiauer3
1Department of Pediatrics, Clinic for Pediatrics and Adolescent Medicine, EVK Hamm, Hamm, Germany.
Frontiers in pediatrics
|May 16, 2025
概括
皮拉戈尼 (Pelargonium sidoides) 根提取物 (EPs 7630) 有效地降低了儿科急性呼吸道感染 (ARTIs) 的严重程度和持续时间. 对儿童ARTIs的其他草药治疗需要进一步的研究.
科学领域:
- 药理学 药理学是指药理学的学科.
- 儿科 儿科 儿科
- 基于证据的医学基于证据的医学.
背景情况:
- 在儿科急性呼吸道感染 (ARTIs) 中,对抗生素替代品的需求日益增加.
- 全球越来越多地使用草药 (植物药品) 来治疗ARTIs.
- 关于植物药物在儿童中有效性的有限的综合证据.
研究的目的:
- 系统地审查关于植物药物治疗儿童ARTIs的疗效和耐受性的证据.
主要方法:
- 在PubMed和Cochrane图书馆进行了全面的文献搜索.
- 遵守系统审查和元分析 (PRISMA) 准则的首选报告项目.
- 包括对儿科上部和下部ARTIs的植物药物临床研究.
主要成果:
- 包括45份报告;只有9份是双盲,安慰剂对照试验.
- 研究的植物药物包括紫草,海德拉螺旋,Pelargonium sidoides (EPs 7630) 和各种固定组合.
- EPs 7630显示了对疗效和耐受性的最强有力的证据.
结论:
- 佩拉戈尼 (Pelargonium sidoides) 根提取物 (EPs 7630) 得到了足够的证据支持,用于治疗儿科ARTIs.
- EPs 7630可以降低儿童上部和下部ARTIs的严重程度和持续时间.
- 由于现有的证据缺陷,需要对其他植物药物进行进一步的研究.
相关概念视频
Drugs Used in Upper Respiratory Disorders: Overview
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...


